Animalcare Group PLC Result of General Meeting, Issue of Equity ... (8419K)
12 July 2017 - 7:40PM
UK Regulatory
TIDMANCR
RNS Number : 8419K
Animalcare Group PLC
12 July 2017
Animalcare Group plc
("Animalcare" or the "Company")
Result of General Meeting, Issue of Equity, Directorate
Change
and Change of Accounting Reference Date
Animalcare Group plc (AIM: ANCR) is pleased to announce that at
its General Meeting today, held in connection with the Placing, the
waiver of Rule 9 of the Takeover Code and the acquisition of
Ecuphar NV (the "Proposals"), as announced on 23 June 2017, all
Resolutions were duly passed. Accordingly, the Acquisition and
Placing are expected to complete tomorrow, 13 July 2017.
In aggregate, 38,691,790 New Ordinary Shares have been allotted
and issued pursuant to the Proposals, comprising 8,571,428 New
Placing Shares, 1,368,896 Option Shares and 28,751,466
Consideration Shares. The New Ordinary Shares have been credited as
fully paid, and will be identical to and rank pari passu in all
respects with the Existing Ordinary Shares.
Trading on AIM of the Existing Ordinary Shares of the Company
will be cancelled at 7.00 a.m. on 13 July 2017. Application has
been made to the London Stock Exchange for the Enlarged Share
Capital in the Company to be admitted to trading on AIM
("Admission"), and it is expected that Admission will become
effective and that dealings in the Enlarged Share Capital will
commence at 8.00 a.m. on 13 July 2017. The ISIN number of the
Ordinary Shares will continue to be GB0032350695. The TIDM will
continue to be ANCR.
The number of Ordinary Shares in issue and the total voting
rights in the Enlarged Group following Admission will be
59,913,900. The Enlarged Group will not hold any Ordinary Shares in
treasury. Shareholders may use this figure of 59,913,900 as the
denominator for the calculations by which they will determine
whether they are required to notify their interest in, or a change
to their interest in, the share capital of the Company under the
Financial Conduct Authority's Disclosure Rules and Transparency
Rules.
Further to the announcement made on 23 June 2017, the Company
can further update that the following changes to the board changes
will take effect conditional on and from Admission:
-- Jan Boone (Non-executive Chairman), Chris Cardon, (Chief
Executive Officer), Walter Beyers (Chief Financial Officer), Edwin
Torr (senior independent Non-executive Director) and Marc Coucke
(Non-executive Director) have been appointed as Directors;
-- Iain Menneer will remain a Director and his role within the
Group will change to Chief Operating Officer;
-- James Lambert will step down as Chairman but will remain on
the Board as a Non-executive Director;
-- Lord Nick Downshire will remain on the Board as a Non-executive Director;
-- Chris Brewster will resign as a Director but will remain a
critical and committed member of the senior management team as
Country Manager of the Enlarged Group's UK business; and
-- Raymond Harding will resign as a Director.
The Company confirms that, also further to the announcement made
on 23 June 2017, its accounting reference date will change to 31
December conditional on and with effect from Admission. In
addition, the resolution to approve the waiver of obligations on
the Concert Party under Rule 9 of the Takeover Code in connection
with the Acquisition was approved on a poll of the Independent
Shareholders. Following Admission, the members of the Concert Party
will have the following interests in Ordinary Shares:
Number of Percentage
Ordinary of Enlarged
Shares Share Capital
Ecuphar Invest NV 13,857,213 23.1%
Alychlo NV 13,857,213 23.1%
Jaak Cardon 84 0.0%*
Total 27,714,510 46.3%
*negligible
Terms used in this announcement shall, unless otherwise
specified, have the meanings given to them in the Company's
admission document dated 24 June 2017, a copy of which is available
to view at
www.animalcaregroup.co.uk/investors/constitutional-documents/aim-admission-document.
Enquiries:
Animalcare Group plc
Iain Menneer, Chief Executive Tel: 01904 487 687
Officer
Chris Brewster, Chief Financial
Officer
Panmure Gordon (UK) Ltd (Nominated Tel: 020 7886 2500
Adviser and Broker)
Corporate Finance
Freddy Crossley / Peter Steel
/ Duncan Monteith
Corporate Broking
James Stearns
Rothschild (Financial Adviser) Tel: 0113 200 1900
Stephen Griffiths
Tim Day
Walbrook PR Ltd Tel: 020 7933 8780 or animalcare@walbrookpr.com
Paul McManus Mob: 07980 541 893
Lianne Cawthorne Mob: 07584 391 303
About Animalcare
Animalcare is a leading veterinary sales and marketing company
based in York with 67 employees including a sales team of 22
selling to veterinary practices around the United Kingdom.
Animalcare has developed a range of generic veterinary medicines
and animal identification products primarily to companion animal
veterinary markets.
Animalcare operates in three product areas:
-- Licensed Veterinary Medicines
-- Animal Welfare Products
-- Companion Animal Identification
For more information see: www.animalcaregroup.co.uk
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCGCGDRLXBBGRD
(END) Dow Jones Newswires
July 12, 2017 05:40 ET (09:40 GMT)
Animalcare (LSE:ANCR)
Historical Stock Chart
From Apr 2024 to May 2024
Animalcare (LSE:ANCR)
Historical Stock Chart
From May 2023 to May 2024